Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.07
-0.11 (-0.83%)
Aug 24, 2026, 4:00 PM EDT - Market closed

Korro Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.386.392.27---
Revenue Growth
-62.08%181.46%----
Cost of Revenue
43.4155.1352.3148--
Gross Profit
-41.02-48.74-50.04-48--
Selling, General & Admin
35.8838.641.8736.5421.3914.06
Research & Development
----37.6121.43
Operating Expenses
35.8838.641.8736.545935.49
Operating Income
-76.9-87.34-91.91-84.53-59-35.49
Other Non Operating Income (Expenses)
5.235.238.473.390.9813.54
EBT Excluding Unusual Items
-72.53-82.11-83.44-81.15-58.02-21.96
Merger & Restructuring Charges
-2.39-3.63----
Asset Writedown
-30.89-30.89----
Pretax Income
-105.81-116.62-83.44-81.15-58.02-21.96
Income Tax Expense
0.840.640.140.030.010
Net Income
-106.64-117.26-83.58-81.17-58.03-21.96
Net Income to Common
-106.64-117.26-83.58-81.17-58.03-21.96
Net Income Growth
------
Shares Outstanding (Basic)
1299204
Shares Outstanding (Diluted)
1299204
Shares Change
28.33%5.32%483.30%499.32%-94.26%-
EPS (Basic)
-8.88-12.48-9.37-53.08-227.42-4.94
EPS (Diluted)
-8.88-12.48-9.37-53.08-227.42-4.94
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-68.27-79.08-77.98-75.12-58.86-36.54
Free Cash Flow Per Share
-5.68-8.42-8.74-49.12-230.65-8.22
Operating Margin
-3228.34%-1366.43%-4047.12%---
Profit Margin
-4477.08%-1834.48%-3680.36%---
Free Cash Flow Margin
-2865.87%-1237.16%-3433.55%---
EBITDA
-74.33-83.06-88.35-80.9-56.49-33.9
D&A For EBITDA
2.574.283.573.632.511.6
EBIT
-76.9-87.34-91.91-84.53-59-35.49
SEC Filings: 10-K · 10-Q